Showing 1 - 10 of 15,309
Gemeinschaftsmarketing für Agrarprodukte und Lebensmittel ist spätestens seit der Ein-führung des Absatzfondsgesetzes im Jahr 1969 das zentrale Instrument zur Absatzförde-rung in der Agrar- und Ernährungswirtschaft. Institutionalisiert in der Centralen Marketing-Gesellschaft der Deutschen...
Persistent link: https://www.econbiz.de/10011375024
This paper is an attempt to provide evidence on two questions: Why do companies sponsor art events, and where exactly does the money go? We analyse data collected on the revenue structure of cultural institutions in Berlin and Hamburg. This data set not only tells us where the money goes, it...
Persistent link: https://www.econbiz.de/10010260636
Die Krise der Medienindustrie ist im wesentlichen eine Krise des Werbemarktes. Angesichts eines Beitrages der Werbung …
Persistent link: https://www.econbiz.de/10010263015
It is sometimes argued that more advertising raises consumption which in turn stimulates output and so economic growth. We test this hypothe- sis using annual German data expressed in terms of GDP for the period 1950-2000. We find that advertising does not Granger-cause growth but Granger-causes...
Persistent link: https://www.econbiz.de/10010266892
Persistent link: https://www.econbiz.de/10010270387
bezüglich der Werbung eine bedeutendere Rolle für die Beeinflussung des Kaufverhaltens als die Werbeeinstellung und eignen sich …
Persistent link: https://www.econbiz.de/10010298433
Persistent link: https://www.econbiz.de/10010303885
Persistent link: https://www.econbiz.de/10011902322
We investigate a linear state differential oligopoly game with advertising, under either Cournot or Bertrand competition. We show that a unique saddlepoint equilibrium exists in both cases if the marginal cost of advertising is sufficiently low. Then, we prove that Bertrand competition entails...
Persistent link: https://www.econbiz.de/10011651458
We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients differ in their susceptibility to the drugs. If DTCA is allowed, this can be employed to induce...
Persistent link: https://www.econbiz.de/10010261296